Latest News & Updates

Webinar Recording

FDA in Motion: Policy Shifts to Focus On in 2026

Watch Now

Back by Popular Demand: All Access Pass Now Available

Maximize your FDA Boot Camp experience with full access to all three workshops – at a value-packed rate.

All Access Pass | Conference + 3 Workshops$2,795 ($4,495 value)
Conference Pass | Conference only$2,095
Workshop Pass | Individual workshops$600 each

Rates increase after October 30.

See Pricing

Who Attends?

This event is designed for professionals involved in navigating FDA regulatory law in real-world settings. Our audience includes:

  • In-house legal teams from leading pharmaceutical, biotechnology, medical device, and diagnostics companies
  • Corporate counsel, general counsel, and regulatory affairs leaders responsible for compliance and product lifecycle management
  • Partners and associates from top law firms focused on FDA, intellectual property, and life sciences litigation
  • Strategic advisors and investment professionals involved in funding or advising FDA-regulated businesses

Past Attending Organizations

Attendees represent companies across the U.S. and globally, including AbbVie, GSK, Merck, Vertex, Novo Nordisk, Regeneron, and dozens more.

Whether you’re an experienced advisor or new to FDA matters, this is your opportunity to build fluency in the concepts, laws, and enforcement trends shaping the life sciences landscape.

View Past Attendees

CLE Accreditation

Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation. Workshop A contains 2 substantive credits and 1 ethics credit. Workshops B and C provide 3 credits each. And the main conference provides a total of 11 hours and 15 minutes of CLE credits.

Learn more

Webinar Recording

FDA in Motion: Policy Shifts to Focus On in 2026

Watch Now

Testimonials

★★★★★
“The speakers and content were second to none. It was a fantastic experience for me to attend.”
—Senior Counsel, GSK
★★★★★
“Very positive. Helpful topic coverage, flagging of issues and current regulatory climate.”
—Corporate Counsel, Ulrey

Questions?

Email us at [email protected]

Get in Touch

Ready to Register?

Secure your space now.

Register Now